...
首页> 外文期刊>Frontiers in Bioengineering and Biotechnology >Identification of Early Warning Signals at the Critical Transition Point of Colorectal Cancer Based on Dynamic Network Analysis
【24h】

Identification of Early Warning Signals at the Critical Transition Point of Colorectal Cancer Based on Dynamic Network Analysis

机译:基于动态网络分析的结直肠癌临界转变点的预警信号鉴定

获取原文
           

摘要

Colorectal cancer (CRC) is one of the leading causes of cancer-related death worldwide. Due to the lack of early diagnosis methods and warning signals of CRC and its strong heterogeneity, the determination of accurate treatments for CRC and the identification of specific early warning signals are still urgent problems for researchers. In this study, the expression profiles of cancer tissues and the expression profiles of tumour-adjacent tissues in 28 CRC patients were combined into a human protein–protein interaction (PPI) network to construct a specific network for each patient. A network propagation method was used to obtain a mutant giant cluster (GC) containing more than 90% of the mutation information of one patient. Next, mutation selection rules were applied to the GC to mine the mutation sequence of driver genes in each CRC patient. The mutation sequences from patients with the same type CRC were integrated to obtain the mutation sequences of driver genes of different types of CRC, which provide a reference for the diagnosis of clinical CRC disease progression. Finally, dynamic network analysis was used to mine dynamic network biomarkers (DNBs) in CRC patients. These DNBs were verified by clinical staging data to identify the critical transition point between the pre-disease state and the disease state in tumour progression. Twelve known drug targets were found in the DNBs, and 6 of them have been used as targets for anticancer drugs for clinical treatment. This study provides important information for the prognosis, diagnosis and treatment of CRC, especially for pre-emptive treatments. It is of great significance for reducing the incidence and mortality of CRC.
机译:结肠直肠癌(CRC)是全世界癌症相关死亡的主要原因之一。由于CRC的早期诊断方法和警告信号及其强烈的异质性,对CRC的准确治疗测定和特定预警信号的鉴定是研究人员的迫切问题。在该研究中,将癌组织和肿瘤相邻组织的表达谱系在28名CRC患者中的表达谱组合成人蛋白质 - 蛋白质相互作用(PPI)网络,以构建每个患者的特定网络。使用网络传播方法来获得含有超过90%的突变信息的突变巨大簇(GC)。接下来,将突变选择规则应用于GC以挖掘每个CRC患者中的驾驶员基因的突变序列。来自相同型CRC患者的突变序列被整合以获得不同类型CRC的驾驶基因的突变序列,这为临床CRC疾病进展的诊断提供了参考。最后,使用动态网络分析在CRC患者中挖掘动态网络生物标志物(DNB)。通过临床分期数据验证这些DNB,以鉴定肿瘤进展中疾病状态和疾病状态之间的关键转变点。在DNB中发现了12个已知的药物靶标,其中6种已被用作抗癌药物的临床治疗靶标。本研究为CRC的预后,诊断和治疗提供了重要信息,特别是对于先发制人的治疗。对CRC的发病率和死亡率具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号